INO
Inovio Accelerates Towards Milestone Approval with Strong Q2 Performance
Inovio, the pioneering biotechnology company, has reported a significant step forward in its second quarter of 2026 financial results. The company's President and CEO, Dr. Jacqueline Shea, led the conference call that revealed Inovio's unwavering commitment to revolutionizing the treatment of chronic diseases. With the FDA&